Ratings by Colliers Securities (Kyle Bauser)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/10/2022 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
3.40 (3.00) |
-11.76% | Details | |
| 3/3/2022 | Streamline Health Solutions | STRM | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2022 | Intricon Corp | IIN | Downgrade | Neutral (Buy) |
17.42 (24.24) |
39.15% | Details | |
| 1/11/2022 | Apollo Medical Holdings | AMEH | New Coverage | Buy (N/A) |
60.06 (40.82) |
-32.03% | Details | |
| 12/27/2021 | UFP Technologies | UFPT | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2021 | Chembio Diagnostics | CEMI | Downgrade | Hold (Buy) |
2.06 (0.46) |
-77.67% | Details | |
| 6/7/2021 | Performant Financial | PFMT | New Coverage | Buy (N/A) |
4.91 (3.56) |
-27.49% | Details | |
| 11/6/2020 | Chembio Diagnostics | CEMI | Upgrade | Buy (Hold) |
4.43 (2.06) |
-53.5% | Details | |
| 6/17/2020 | Chembio Diagnostics | CEMI | Downgrade | Hold (Buy) |
9.93 (0.46) |
-95.37% | Details |
